Study to Evaluate the Long-term Safety of Rusfertide (PTG-300) in Subjects With Polycythemia Vera

NCT06033586 · clinicaltrials.gov ↗
PHASE3
Phase
ACTIVE_NOT_RECRUITING
Status
46
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Protagonist Therapeutics, Inc.